Ferric citrate vs. sevelamer carbonate (used for high phosphate ) as a phosphate binder drug in patients with chronic kidney disease on hemodialysis.
Phase 4
- Conditions
- Health Condition 1: N186- End stage renal disease
- Registration Number
- CTRI/2024/04/066516
- Lead Sponsor
- Christian Medical College and Hospital, Ludhiana
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Aged 18 years and above
2.Patients of both genders will be included in the study
3.Patients with the diagnosis of chronic kidney disease undergoing hemodialysis for at least 6 weeks
4.Elevated baseline serum phosphorus ( > 5.5 mg/dl)
Exclusion Criteria
1.Significant gastrointestinal disorder (including known active peptic ulcer, Crohn’s disease, ulcerative colitis, irritable bowel syndrome, GI motility disorder)
2.Current malignancy
3.Pregnant and lactating women
4.Known hypersensitivity to phosphate binders
5.Other drugs affecting phosphorus metabolism (steroids, alcohol intake and use of other phosphate binders)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method